MAXINE GOWEN

Insider Reports History

Location
San Diego, CA
Signature
/s/ Peter Silverman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MAXINE GOWEN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Merus N.V. Director Share Option (right to buy) 0 $119,571 $13.52 12 Dec 2025 Direct
Aclaris Therapeutics, Inc. Director Common Stock 21,754 $33,283 $1.53 06 Jun 2025 Direct
Aclaris Therapeutics, Inc. Director Restricted Stock Units 0 $4,937 $1.03 06 Jun 2025 Direct
Passage BIO, Inc. Director Director Stock Option (right to buy) 201,857 28 May 2025 Direct
Aclaris Therapeutics, Inc. Director Stock Option (Right to Buy) 42,350 05 Jun 2025 Direct
Aceragen, Inc. Director Common Stock 0 $0.5100 10 Aug 2023 By Trust

Insider Reports Filed by MAXINE GOWEN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRUS Merus N.V. 12 Dec 2025 6 $0 4 Director 12 Dec 2025, 18:49
ACRS Aclaris Therapeutics, Inc. 05 Jun 2025 4 $0 4 Director 09 Jun 2025, 16:20
PASG Passage BIO, Inc. 28 May 2025 1 $0 4 Director 30 May 2025, 19:31
MRUS Merus N.V. 22 May 2025 1 $0 4 Director 27 May 2025, 08:00
ACRS Aclaris Therapeutics, Inc. 06 Jun 2024 2 $0 4 Director 10 Jun 2024, 16:15
ACRS Aclaris Therapeutics, Inc. 01 Jun 2024 2 $0 4 Director 04 Jun 2024, 16:30
PASG Passage BIO, Inc. 21 May 2024 1 $0 4 Director 23 May 2024, 16:56
MRUS Merus N.V. 07 May 2024 1 $0 4 Director 09 May 2024, 16:30
/report/000141588923012145-gowen-maxine-2023-08-10 Aceragen, Inc. 10 Aug 2023 1 -$26.01 4 Director 11 Aug 2023, 16:48
MRUS Merus N.V. 08 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:15
ACRS Aclaris Therapeutics, Inc. 01 Jun 2023 4 $0 4 Director 05 Jun 2023, 17:04
PASG Passage BIO, Inc. 25 May 2023 1 $0 4 Director 26 May 2023, 16:24
/report/000141588922006943-gowen-maxine-2022-06-23 IDERA PHARMACEUTICALS, INC. 23 Jun 2022 1 $0 4 Director 27 Jun 2022, 16:31
ACRS Aclaris Therapeutics, Inc. 02 Jun 2022 4 $0 4 Director 06 Jun 2022, 17:15
MRUS Merus N.V. 31 May 2022 1 $0 4 Director 02 Jun 2022, 16:06
PASG Passage BIO, Inc. 31 May 2022 1 $0 4 Director 01 Jun 2022, 16:27
PASG Passage BIO, Inc. 26 May 2022 1 $0 4 Director 31 May 2022, 16:22
/report/000141588921002922-gowen-maxine-2021-06-08 IDERA PHARMACEUTICALS, INC. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 17:25
ACRS Aclaris Therapeutics, Inc. 03 Jun 2021 2 $0 4 Director 04 Jun 2021, 19:55
MRUS Merus N.V. 28 May 2021 1 $0 4/A Director 16 Jun 2021, 16:05
MRUS Merus N.V. 28 May 2021 0 $0 3 Director 02 Jun 2021, 16:05
PASG Passage BIO, Inc. 27 May 2021 1 $0 4 Director 01 Jun 2021, 13:51